Invea Therapeutics Appoints Mr. Jason Fenton to Its Board of Directors
December 06, 2022 08:10 ET
|
Invea Therapeutics
- Mr. Fenton augments board expertise as the Company readies for Phase 1b/2 execution of lead program targeting mast cell biology - Company also primed to advance additional programs, including a...
Artificial Intelligence in Healthcare Market to hit USD 70 Billion by 2032, says Global Market Insights Inc.
December 05, 2022 09:10 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Dec. 05, 2022 (GLOBE NEWSWIRE) -- The AI in healthcare market value is set to surpass over USD 70 billion by 2032, according to a new research report by Global Market...
Lantern Pharma to Participate at the RHK Capital Disruptive Growth Conference on December 5 at 12:00 p.m. ET
December 02, 2022 08:00 ET
|
Lantern Pharma Inc.
DALLAS, Dec. 02, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Lantern Pharma Inc (Nasdaq: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence...
Orion Biotechnology Shares In Vivo Efficacy Data on its Latest Best-in-Class Drug Candidate
December 01, 2022 11:08 ET
|
Orion Biotechnology Canada Ltd.
Ottawa, Canada, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously undruggable G...
Researchers from Insilico Medicine, University of Copenhagen, and University of Chicago unravel molecular secrets hidden in premature aging diseases and cancer using AI
December 01, 2022 09:00 ET
|
InSilico Medicine
New York, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, and the University of Copenhagen announced...
Immuno-oncology Global Market Report 2022: Approval of Novel Therapies Boosts Sector Growth
November 30, 2022 05:48 ET
|
Research and Markets
Dublin, Nov. 30, 2022 (GLOBE NEWSWIRE) -- The "Immuno-oncology Market Size, Share, Trends, Analysis and Forecast by Region, Segment, Type (Checkpoint Modulators, Cancer Vaccines) and End-User...
Insilico Medicine to Present at 41st Annual J.P. Morgan Healthcare Meeting
November 29, 2022 09:00 ET
|
InSilico Medicine
New York, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine will present at the 41st Annual J.P. Morgan Healthcare Meeting happening Jan. 9-12, 2023 at the Westin St. Francis Hotel in San...
Managing Vendor/CRO (Contract Research Organisation)/CMO (Contract Manufacturing Organisation) Oversight Training Course (January 16-17, 2023)
November 25, 2022 04:08 ET
|
Research and Markets
Dublin, Nov. 25, 2022 (GLOBE NEWSWIRE) -- The "Managing Vendor/CRO (Contract Research Organisation)/CMO (Contract Manufacturing Organisation) Oversight Training Course" conference has been added to ...
Insilico Medicine Awarded Over $700,000 to Design New Contraceptive Options with AI
November 23, 2022 09:00 ET
|
InSilico Medicine
New York, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical stage, end-to-end artificial intelligence (AI)-driven drug discovery company, is designing new non-hormonal contraceptive...
RxCelerate Acquires Methuselah Health and Launches ProQuant™ World-Beating Proteomics Service
November 22, 2022 08:00 ET
|
RxCelerate
CAMBRIDGE, England, Nov. 22, 2022 (GLOBE NEWSWIRE) -- RxCelerate, a leading international out-sourced drug discovery and development platform, today announced the acquisition of drug discovery...